Professional Bio
Associate Editor, Pain
Editorial Board, Journal of Pain
Editorial Board, Current Pain and Headache Reports
Professional Advisory Board, American Chronic Pain Association
Neuropathic Pain Management Medical Advisory Council, Neuropathy Association
Zoster Working Group, Centers for Disease Control and Prevention
Special Government Employee, Center for Drug Evaluation and Research, Food and Drug Administration
Director, Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION), a public-private partnership with the Food and Drug Administration (http://www.acttion.org)
Charlie Rose-Eric Kandel Brain Series episode on pain: http://www.charlierose.com/view/interview/12670
Research Bio
Research Interests:
Methodologic aspects of analgesic clinical trials
Treatment and prevention of chronic pain
Neuropathic pain
Osteoarthritis
My current research focuses on methodologic aspects of acute and chronic pain clinical trials, especially identifying factors that increase the assay sensitivity of a trial to detect differences between an active and a control or comparison treatment. With funding from the US Food and Drug Administration (FDA), we are examining in large databases of acute and chronic pain trials the relationships between study methodologic features and study outcomes and placebo group responses, as well as comparing the responsiveness to treatment effects of different primary and secondary outcome measures. These studies and other efforts to improve the efficiency and informativeness of analgesic clinical trials are being conducted under the auspices of the Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) public-private partnership with the FDA, of which I serve as director.
In addition, in collaboration with Dennis Turk at the University of Washington, we are currently conducting a randomized clinical trial of tramadol, cognitive-behavior therapy, and health education alone and in combination for the treatment of fibromyalgia.
I have also been very interested in the identification of risk factors for the development of chronic neuropathic pain. One of our major results has been that patients with greater acute pain are more likely to develop chronic pain. This suggests that attenuating acute pain might prevent chronic pain, and an additional focus of my research has involved developing approaches to test this hypothesis.
Funding
1R01 AR059102-01A (9/1/11-7/31/16)
NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases
Combined behavioral and analgesic trial for fibromyalgia (COMBAT-FM)
Role: Principal Investigator
U01 FD004187-01 (9/15/11-8/31/16)
Food and Drug Administration
Analgesic clinical trial innovations, opportunities, and networks (ACTION)
Role: Principal Investigator
T32 NS007338 (7/1/90-6/30/15)
NIH/National Institute of Neurological Disorders and Stroke
Experimental therapeutics of neurological disease
Role: Preceptor
2014 May
Dworkin RH, O'Connor AB, Kent J, Mackey SC, Raja SN, Stacey BR, Levy RM, Backonja M, Baron R, Harke H, Loeser JD, Treede RD, Turk DC, Wells CD. "Response to letter to the Editor." Pain.. 2014 May; 155(5):1045-6. Epub 2014 Feb 07. |
2014 Apr 9
Munch T, Dufka FL, Greene K, Smith SM, Dworkin RH, Rowbotham MC. "RReACT Goes Global: Perils and Pitfalls of Constructing a Global Open-Access Database of Registered Analgesic Clinical Trials and Trial Results." Pain.. 2014 Apr 9; Epub 2014 Apr 09. |
2014 Mar
Dworkin RH, McDermott MP, Farrar JT, O'Connor AB, Senn S. "Interpreting patient treatment response in analgesic clinical trials: implications for genotyping, phenotyping, and personalized pain treatment." Pain.. 2014 Mar; 155(3):457-60. Epub 2013 Sep 23. |
2014 Mar
Gewandter JS, Smith SM, McKeown A, Burke LB, Hertz SH, Hunsinger M, Katz NP, Lin AH, McDermott MP, Rappaport BA, Williams MR, Turk DC, Dworkin RH. "Reporting of primary analyses and multiplicity adjustment in recent analgesic clinical trials: ACTTION systematic review and recommendations." Pain.. 2014 Mar; 155(3):461-6. Epub 2013 Nov 23. |
2014 Mar
Fillingim RB, Bruehl S, Dworkin RH, Dworkin SF, Loeser JD, Turk DC, Widerstrom-Noga E, Arnold L, Bennett R, Edwards RR, Freeman R, Gewandter J, Hertz S, Hochberg M, Krane E, Mantyh PW, Markman J, Neogi T, Ohrbach R, Paice JA, Porreca F, Rappaport BA, Smith SM, Smith TJ, Sullivan MD, Verne GN, Wasan AD, Wesselmann U. "The ACTTION-American Pain Society Pain Taxonomy (AAPT): An Evidence-Based and Multidimensional Approach to Classifying Chronic Pain Conditions." The journal of pain : official journal of the American Pain Society.. 2014 Mar; 15(3):241-9. |
